Christopher L. Lotz
Net Worth

Last updated:

What is Christopher L. Lotz net worth?

The estimated net worth of Mr. Christopher L. Lotz is at least $2,338,028 as of 16 Apr 2021. He owns shares worth $23,828 as insider and has received compensation worth at least $2,314,200 in Qualigen Therapeutics, Inc..

What is the salary of Christopher L. Lotz?

Mr. Christopher L. Lotz salary is $578,550 per year as Vice President of Fin. & Chief Financial Officer in Qualigen Therapeutics, Inc..

How old is Christopher L. Lotz?

Mr. Christopher L. Lotz is 60 years old, born in 1965.

What stocks does Christopher L. Lotz currently own?

As insider, Mr. Christopher L. Lotz owns shares in one company:

Company Title Shares Price per share Total value
Qualigen Therapeutics, Inc. (QLGN) Vice President of Fin. & Chief Financial Officer 12,541 $1.9 $23,828

What does Qualigen Therapeutics, Inc. do?

Qualigen Therapeutics, Inc., a biotechnology company, develops novel therapeutic products for the treatment of cancer and infectious diseases. It offers FastPack, a rapid diagnostic testing system. The company is developing QN-302 for the treatment of pancreatic ductal adenocarcinoma; QN-247, a DNA coated gold nanoparticle cancer drug candidate that targets various cancers; RAS-F, a small-molecule RAS oncogene protein-protein inhibitor that blocks RAS mutations and inhibits tumor formation; and STARS blood cleansing system, a DNA/RNA-based treatment device that removes tumor-produced compounds and viruses from a patient's blood. Qualigen Therapeutics, Inc. was founded in 1996 and is based in Carlsbad, California.

Christopher L. Lotz insider trading

Qualigen Therapeutics, Inc.

Transaction Date Security Shares Price per share Total value Source
Purchase
Common Stock 2,700 $1.86 $5,022

Qualigen Therapeutics key executives

Qualigen Therapeutics, Inc. executives and other stock owners filed with the SEC: